Page last updated: 2024-08-26

lysophosphatidic acid and Cardiotoxicity

lysophosphatidic acid has been researched along with Cardiotoxicity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Du, X; Guo, S; Jiang, C; Li, X; Liu, J; Ma, Y; Mei, S; Sun, N; Tang, K; Wang, X; Zhao, D1

Other Studies

1 other study(ies) available for lysophosphatidic acid and Cardiotoxicity

ArticleYear
18:0 Lyso PC, a natural product with potential PPAR-γ agonistic activity, plays hypoglycemic effect with lower liver toxicity and cardiotoxicity in db/db mice.
    Biochemical and biophysical research communications, 2021, 11-19, Volume: 579

    Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Biological Products; Cardiotoxicity; Chemistry, Pharmaceutical; Diabetes Mellitus, Type 2; Fatty Acids; Heart; Hypoglycemic Agents; Lipids; Liver; Lysophospholipids; Male; Medicine, Chinese Traditional; Mice; Molecular Docking Simulation; PPAR gamma; Rosiglitazone

2021